|Protocol #||Sponsor||Protocol Title|
EMR 100070-001, 2013-002834-19
|A Phase I, Open-Label, Multiple-Ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of Avelumab (MSB0010718C) in Subjects with Metastatic or Locally Advanced Solid Tumors and Expansion to Selected Indications|
B9991009, 2015-003091-77, JAVELIN OVARIAN 200
|A Phase 3, Multi-Center, Randomized, Open-label Study Of Avelumab (MSB0010718C) Alone Or In Combination with Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients with Platinum-Resistant/Refractory Ovarian Cancer|
Northwest Georgia Oncology Centers‘ (NGOC) physicians work with gynecologic oncologists to provide expert care to patient with ovarian cancer.